← Eichor
Condition: Pharmacokinetics Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pharmacokinetics

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
Phase 1 · 1 location(s) · Ascentage Pharma Group Inc. · NCT06687070Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS
Phase 1 · 2 location(s) · HTIC, Inc · NCT07449572Population Pharmacokinetics of Anti-infectives in Critically Ill Children
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT02539407Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT04778839Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1 · 40 location(s) · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06625775A Food-Effect Study of CX11 in Healthy Participants
Phase 1 · 1 location(s) · Vincentage Pharma Co., Ltd · NCT07349381A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight
Phase 1 · 1 location(s) · Suzhou Alphamab Co., Ltd. · NCT06547775A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic
Phase 1 · 26 location(s) · R-Pharm · NCT07543744Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors
Phase 1 · 1 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07482592Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery
Phase 1 · 1 location(s) · CSPC Ouyi Pharmaceutical Co., Ltd. · NCT07519109Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function
Phase 1 · 1 location(s) · Jiangsu vcare pharmaceutical technology co., LTD · NCT07551557Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis
Phase N/A · 1 location(s) · Beijing Children's Hospital · NCT03625739To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Health
Phase 1 · 1 location(s) · Shenzhen Kexing Pharmaceutical Co., Ltd. · NCT07237464Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients
Phase N/A · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07612163Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Phase 2 · 43 location(s) · Vertex Pharmaceuticals Incorporated · NCT07161037Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors
Phase 1 · 1 location(s) · Trutino Biosciences Inc. · NCT06770764Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN
Phase 2 · 6 location(s) · Omeros Corporation · NCT06209736A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
EARLY_Phase 1 · 5 location(s) · Nanjing Legend Biotech Co. · NCT07095075Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute
Phase 2 · 11 location(s) · ReAlta Life Sciences, Inc. · NCT06343792A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term Hypoparathyroidism
Phase 3 · 3 location(s) · Ascendis Pharma A/S · NCT07706764Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation
Phase 4 · 2 location(s) · Hospices Civils de Lyon · NCT05743400Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
Phase 1 · 2 location(s) · University of Chicago · NCT04295863A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Phase 1/Phase 2 · 22 location(s) · Forward Pharmaceuticals Co., Ltd. · NCT06064812Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT05069688A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 · 19 location(s) · Merck Sharp & Dohme LLC · NCT07247110A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injectio
Phase 1 · 65 location(s) · GlaxoSmithKline · NCT06431594A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or M
Phase 1/Phase 2 · 4 location(s) · Genentech, Inc. · NCT07567846TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
Phase 1 · 2 location(s) · Shenzhen TargetRx Co., Ltd. · NCT06088888A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
Phase 1/Phase 2 · 1 location(s) · SUNHO（China）BioPharmaceutical CO., Ltd. · NCT05991583Clofutriben Pharmacokinetics in Patients With Impaired Renal Function
Phase 1 · 1 location(s) · Sparrow Pharmaceuticals · NCT07227922
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.